News

Key Points Analyst expectations are far above the prices you'd need to pay now to own a couple of biotechnology stocks.Compass Pathways is developing psilocybin as a treatment for depression.Viking ...
The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...